| Mark Tye Haeberle, | |
|
3810 Springhurst Blvd, Suite 200, Louisville, KY 40241 | |
| (502) 583-1749 | |
| (502) 329-8184 |
| Full Name | Mark Tye Haeberle |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 13 Years |
| Location | 3810 Springhurst Blvd, Louisville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558650291 | NPI | - | NPPES |
| 7100215390 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 47890 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associates In Dermatology, Pllc | 1658263876 | 32 |
| Associates In Dermatology, Pllc | 1658263876 | 32 |
News Archive
A study from researchers at Massachusetts General Hospital and Brigham and Women's Hospital reveals for the first time exactly how mutations associated with the most common form of inherited Alzheimer's disease produce the disorder's devastating effects.
Bariatric surgery is not only cost-effective for treating people who are severely obese, but also for those who are mildly obese, according to a new study from Washington University School of Medicine in St. Louis.
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,386,027, "Skin Permeation Device For Analyte Sensing or Transdermal Drug Delivery," for the Prelude SkinPrep System, the skin permeation component of the Symphony CGM System.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
To facilitate the rapid dissemination of COVID-19 findings, Academic Emergency Medicine (AEM) journal, in collaboration with Wiley Publishing, is fast-tracking submissions related to COVID-19 and making the latest, most relevant research available in an easy-to-navigate, freely accessible online collection of accepted and citable articles.
› Verified 9 days ago
| Entity Name | Associates In Dermatology, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629083399 PECOS PAC ID: 1658263876 Enrollment ID: O20040325000047 |
News Archive
A study from researchers at Massachusetts General Hospital and Brigham and Women's Hospital reveals for the first time exactly how mutations associated with the most common form of inherited Alzheimer's disease produce the disorder's devastating effects.
Bariatric surgery is not only cost-effective for treating people who are severely obese, but also for those who are mildly obese, according to a new study from Washington University School of Medicine in St. Louis.
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,386,027, "Skin Permeation Device For Analyte Sensing or Transdermal Drug Delivery," for the Prelude SkinPrep System, the skin permeation component of the Symphony CGM System.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
To facilitate the rapid dissemination of COVID-19 findings, Academic Emergency Medicine (AEM) journal, in collaboration with Wiley Publishing, is fast-tracking submissions related to COVID-19 and making the latest, most relevant research available in an easy-to-navigate, freely accessible online collection of accepted and citable articles.
› Verified 9 days ago
| Entity Name | University Of Louisville Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366722316 PECOS PAC ID: 3476725599 Enrollment ID: O20111017000036 |
News Archive
A study from researchers at Massachusetts General Hospital and Brigham and Women's Hospital reveals for the first time exactly how mutations associated with the most common form of inherited Alzheimer's disease produce the disorder's devastating effects.
Bariatric surgery is not only cost-effective for treating people who are severely obese, but also for those who are mildly obese, according to a new study from Washington University School of Medicine in St. Louis.
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,386,027, "Skin Permeation Device For Analyte Sensing or Transdermal Drug Delivery," for the Prelude SkinPrep System, the skin permeation component of the Symphony CGM System.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
To facilitate the rapid dissemination of COVID-19 findings, Academic Emergency Medicine (AEM) journal, in collaboration with Wiley Publishing, is fast-tracking submissions related to COVID-19 and making the latest, most relevant research available in an easy-to-navigate, freely accessible online collection of accepted and citable articles.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark Tye Haeberle, Po Box 950132, Louisville, KY 40295-0132 Ph: (888) 980-8992 | Mark Tye Haeberle, 3810 Springhurst Blvd, Suite 200, Louisville, KY 40241 Ph: (502) 583-1749 |
News Archive
A study from researchers at Massachusetts General Hospital and Brigham and Women's Hospital reveals for the first time exactly how mutations associated with the most common form of inherited Alzheimer's disease produce the disorder's devastating effects.
Bariatric surgery is not only cost-effective for treating people who are severely obese, but also for those who are mildly obese, according to a new study from Washington University School of Medicine in St. Louis.
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,386,027, "Skin Permeation Device For Analyte Sensing or Transdermal Drug Delivery," for the Prelude SkinPrep System, the skin permeation component of the Symphony CGM System.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
To facilitate the rapid dissemination of COVID-19 findings, Academic Emergency Medicine (AEM) journal, in collaboration with Wiley Publishing, is fast-tracking submissions related to COVID-19 and making the latest, most relevant research available in an easy-to-navigate, freely accessible online collection of accepted and citable articles.
› Verified 9 days ago
Mrs. Jyoti B. Burruss, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3810 Springhurst Blvd, Suite 200, Louisville, KY 40241 Phone: 502-583-1749 Fax: 502-329-8184 | |
Dr. Jae Yeon Jung, M.D., PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3810 Springhurst Blvd Ste 200, Louisville, KY 40241 Phone: 502-583-1749 Fax: 502-329-8184 | |
Vilma C Fabre, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2211 Greene Way, Ste 100, Louisville, KY 40220 Phone: 502-495-1162 Fax: 502-495-0156 | |
Elizabeth Veasey, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 800 Zorn Ave, Louisville, KY 40206 Phone: 502-287-4000 | |
Andrea S Burch, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2307 Greene Way Ste C, Louisville, KY 40220 Phone: 502-806-3376 Fax: 502-213-3999 | |
Dr. Steven J Hodge, MD Dermatology Medicare: Medicare Enrolled Practice Location: 310 E Broadway, Ste 200, Louisville, KY 40202 Phone: 502-585-5249 Fax: 502-585-5251 | |
Dr. Michael Mccall Jr., M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3810 Springhurst Blvd, Suite 200, Louisville, KY 40241 Phone: 502-322-1946 Fax: 502-329-8184 |